查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
细胞流式细胞仪的全球市场:网站各类型电表，各企业规模，各主要地区:产业趋势与全球预测，2022年～2035年
市场调查报告书
商品编码
1169195

细胞流式细胞仪的全球市场:网站各类型电表，各企业规模，各主要地区:产业趋势与全球预测，2022年～2035年

Global Cell Cytometry Market Distribution by Type of Cytometer, Company Size and Key Geographical Regions : Industry Trends and Global Forecasts, 2022-2035
出版日期: | 出版商: Roots Analysis | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

本报告提供全球细胞流式细胞仪市场相关调查，市场概要，以及各流式细胞仪类型，各企业规模，各主要地区的趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 序文

第2章 摘要整理

第3章 简介

  • 章概要
  • 细胞流式细胞仪
  • 细胞流式细胞仪的优点与限制
  • 有关细胞流式细胞仪的一般趋势

第4章 高通量流式细胞仪:市场形势

  • 章概要
  • 高通量流式细胞仪:整体市场形势
  • 高通量流式细胞仪:开发商的形势

第5章 产品竞争力分析:高通量流式细胞仪

  • 章概要
  • 假设/主要的参数
  • 调查手法
  • 产品竞争力分析
    • 把北美作为据点的开发商
    • 把欧洲和亚洲作为据点的开发商

第6章 印象网站仪表:市场形势

  • 章概要
  • 印象网站仪表:整体市场形势
  • 印象网站仪表:开发商的形势

第7章 产品竞争力分析:印象网站仪表

  • 章概要
  • 假设/主要的参数
  • 调查手法
  • 产品竞争力分析

第8章 全球细胞流式细胞仪:企业简介

  • 章概要
  • Agilent
  • Beckman Coulter Life Sciences
  • Becton Dickinson
  • Bio-Rad
  • Chemometec
  • Milkotronic
  • Nexcelom Bioscience
  • Sartorius
  • Sony Biotechnology
  • ThermoFisher Scientific
  • Union Biometrica

第9章 全球细胞流式细胞仪:伙伴关係和合作

第10章 最近的发展

第11章 专利分析

第12章 市场预测

  • 章概要
  • 主要的假设与调查手法
  • 全球细胞流式细胞仪市场，2022年～2035年

第13章 结论

第14章 执行见解

第15章 附录1:表格形式的资料

第16章 附录2:公司及组织的清单

Product Code: RA100398

INTRODUCTION

Novel cell cytometry devices have recently emerged as crucial analytical and visualization tools that have revolutionized the global cell cytometry industry. These technologically driven tools are used for multiple purposes in the research industry, such as identification and analysis of cells in a biological sample, cell characterization, cell sorting, cell cycle analyses, cell proliferation assays, immunophenotyping and hematological studies. ,

Q1. What are the limitations of conventional cell cytometers?

The key concerns related to traditional cell cytometers include long turnover rates and poor visualization of analysis output. In addition, the conventional systems are incapable of handling large sample size and lack data processing software.

Q2. What are the different types of novel cell cytometers? What are the key advantages offered by novel cell cytometers?

In order to overcome the challenges of conventional cell cytometers, several medical device companies have developed technologically advanced variants of cell cytometers, including flow cytometers, facs flow cytometers, image cytometers, and time lapse cytometers. These novel devices offer various advantages; for instance, the high throughput flow cytometers have the ability to rapidly analyze large libraries of cells at once and allow the measurement of various characteristics of a sample. On the other hand, image cytometers are designed to visualize the cells and analyze multiple parameters of the sample using various proprietary features, such as spectral absorbance, multiple fluorescence channels, brightfield microscopy and luminescence at a greater speed.

Q3. What is the current market landscape of global high throughput flow cytometers and image cytometers market?

Presently, more than 180 high throughput flow / image cytometers that offer improved turnaround time and ease of operability are available in the market to streamline analytical workflows. It is worth highlighting that several novel cell cytometer developers have entered into strategic alliances in order to enhance their existing product capabilities and consolidate their presence in this domain. Additionally, close to 80% of the global events in this industry have been organized, since 2020. Several patents related to high throughput flow cytometers and image cytometers have been recently filed / granted, demonstrating the continuous innovation in this domain.

Q4. What are the key value drivers in the global cell cytometry market, focusing on high throughput flow cytometers and image cytometers?

In the recent years, the global cell cytometry market has witnessed an increase in the demand for advanced cell analyzers that are capable of not only counting / sorting the cells but also offer assessment of cell functions / characteristics in addition to the identification of potential biomarkers. Additionally, the adoption of high throughput flow cytometers and image cytometers in novel research application areas, including proteomics, cytogenomics and oncology research, has further contributed to the growth of this market.

Q5. What is the current / future market size of global cell cytometry market, focusing on high throughput flow cytometers and image cytometers? Which segments of this market are anticipated to capture the major share?

The global cell cytometry market, focusing on high through flow cytometers and image cytometers, is projected to grow at a CAGR of 8.6% in the coming years. Currently, in terms of type of cytometer, the market is captured by high throughput cell cytometers. However, this trend is expected to change in the foreseen future as the demand for image cytometers is anticipated to increase in the next 8 years. Specifically, in terms of geography, the market in North America is likely to grow at a relatively faster pace in the long term.

Q6. Who are the key players engaged in the global cell cytometry market, focusing on high through flow cytometers and image cytometers?

Examples of key players engaged in this domain (which have also been captured in this report) include Agilent, Beckton Dickinson, Beckman Coulter Life Sciences, Bio-Rad, Chemometec, Milkotronic, Nexcelom Bioscience, Sartorius, Sony Biotechnology, ThermoFisher Scientific and Union Biometrica.

SCOPE OF THE REPORT

The "Global Cell Cytometry Market, Focus on High Throughput Flow Cytometers and Image Cytometers by Type of Cytometer (High Throughput Flow Cytometers and Image Cytometers), Company Size (Very Small, Small, Mid-sized, Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035" report features an extensive study on the current market landscape and future potential of high throughput flow cytometers and image cytometers, over the next decade. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. In addition to other elements, the report includes:

  • A general overview of cell cytometry, featuring information on the different types of cytometry, namely high throughput flow cytometry and image cytometry, along with details on their advantages and limitations. Further, the chapter presents an array of Google trends analysis, highlighting the emerging focus areas, key historical trends, and geographical activity, offering insights on how this field has evolved over the last five years.
  • A detailed assessment of the market landscape of high throughput flow cytometers based on several relevant parameters, such as type of high throughput flow cytometer, throughput rate (wells per minute), detection rate, type of plate format, number of color channels, number of laser channels, number of detection channels, product dimensions (W×D×H), sample volume (in µl), type of detection mechanism(s), and application(s). In addition, the chapter includes analysis of high throughput flow cytometer developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of products offered).
  • An insightful product competitiveness analysis of high throughput flow cytometers, based on developer power (based on the experience of the developer in this industry), and product competitiveness (in terms of type of high throughput flow cytometer, throughput rate, detection rate, type of plate format, number of color channels, number of laser channels, number of detection channels, product dimensions, sample volume (in µl), type of detection mechanism(s) and application(s)).
  • A detailed assessment of the market landscape of image cytometers based on several relevant parameters, such as type of image cytometer, processing time, type of plate format, output format, sample volume, product dimensions (W×D×H) and application(s). In addition, the chapter includes analysis of image cytometer developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of products being offered).
  • An insightful product competitiveness analysis of image cytometers, based on developer power (based on the experience of the developer in this industry), and product competitiveness (in terms of type of image cytometer, processing time, output format, average sample volume and application(s)).
  • Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in the development / commercialization of cell cytometers (high throughput flow cytometers and image cytometers). Each profile features a brief overview of the company, recent developments and an informed future outlook.
  • An insightful analysis of the partnerships that have been inked within the global cell cytometry industry since 2017, based on several relevant parameters, such as year of partnership, type of partnership (acquisitions, asset acquisitions, commercialization agreements, commercialization and distribution agreements, distribution agreements, product development agreements storage and distribution agreements and others), most active players (in terms of number of deals inked) and regional distribution of partnership activity.
  • An analysis of various recent developments / trends related to global cell cytometry domain, offering insights on the funding activity in this domain, based on several relevant parameters, such as year of funding, type of funding, amount invested (USD Million), most active players (in terms of number of instances and amount raised), and most active investors (in terms of number of instances). In addition, it provides information on the analysis of the global events attended by the participants, based on several relevant parameters, such as year of event, event platform, type of event, most active organizers (in terms of number of events) and most active organizations (in terms of number of participants).
  • An insightful analysis of the patents filed / granted for cell cytometry, since 2020, taking into consideration various relevant parameters, such as type of patent, publication year, annual number of granted patents and patent applications, geographical location, CPC symbols, emerging focus areas, type of organization, leading players (in terms of number of patents granted / filed) and patent characteristics. In addition, the chapter includes a detailed patent benchmarking and an insightful valuation analysis.

One of the key objectives of the report was to estimate the existing market size and the future opportunity for cell cytometry, over the coming 13 years. We have provided informed estimates on the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of cytometer (high throughput flow cytometers and image cytometers), company size (very small, small, mid-sized, large, and very large) and key geographical regions (North America, Europe, Asia-Pacific, and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the anticipated industry's growth. The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews / surveys with experts in the area (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:

  • Annual reports
  • Investor presentations
  • SEC filings
  • Industry databases
  • News releases from company websites
  • Government policy documents
  • Industry analysts' views

While the focus has been on forecasting the market till 2035, the report also provides our independent view on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

  • Which are the popular types of cytometers available in the market?
  • Who are the leading players engaged in the development of high throughput flow cytometers and image cytometers?
  • Which partnership models are commonly adopted by stakeholders engaged in this industry?
  • What are the investment trends in the global cell cytometry industry?
  • Who are the key investors that are actively engaged in supporting the development and commercialization of cell cytometers?
  • What are the key agenda items being discussed in various global events / conferences that are related to cell cytometry?
  • How has the patent landscape evolved in this industry?
  • What will be the total market value of the global cell cytometry market in 2035?
  • Which key geographical region of the global cell cytometry market is expected to witness the highest growth?

CHAPTER OUTLINES

Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of the global cell cytometry market and its likely evolution in the short-mid to long term.

Chapter 3 provides a brief overview of cell cytometry and its types, named high throughput flow cytometry and image cytometry, along with details on their advantages and limitations. Further, the chapter presents an array of Google trends analysis, highlighting the emerging focus areas, key historical trends, and geographical activity, offering insights on how this field has evolved over the last five years.

Chapter 4 presents an overview of the current market landscape of high throughput flow cytometers, featuring a detailed analysis of these systems based on several parameters, such as type of high throughput flow cytometer, throughput rate (wells per minute), detection rate, type of plate format, number of color channels, number of laser channels, number of detection channels, product dimensions (W×D×H), sample volume (in µl), type of detection mechanism(s), and application(s). In addition, the chapter includes analysis of high throughput flow cytometer developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of products offered).

Chapter 5 is an insightful product competitiveness analysis of high throughput flow cytometers, provided by developers which are based in North America, Europe, and Asia-Pacific. The products considered in this analysis were scored on several relevant parameters, such as developer power (in terms of number of years of experience of a company), and product competitiveness (in terms of type of high throughput flow cytometer, throughput rate, detection rate, type of plate format, number of color channels, number of laser channels, number of detection channels, product dimensions, sample volume (in µl), type of detection mechanism(s) and application(s)).

Chapter 6 presents an overview of the current market landscape of image cytometers, featuring a detailed analysis of these systems based on several parameters, such as type of image cytometer, processing time, type of plate format, output format, sample volume, product dimensions (W×D×H) and application(s). In addition, the chapter includes analysis of image cytometer developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of products being offered).

Chapter 7 is an insightful product competitiveness analysis of image cytometers, provided by developers which are based in North America, Europe, and Asia-Pacific. The products considered in this analysis were scored on several relevant parameters, such as developer power (in terms of number of years of experience of a company), and product competitiveness (type of image cytometer, processing time, output format, average sample volume and application(s)).

Chapter 8 provides detailed profiles of key players engaged in the development of high throughput flow cytometers and image cytometers. Each profile features a brief overview of the company, recent developments and an informed future outlook.

Chapter 9 features an insightful analysis of the partnerships that have been inked within the global cell cytometry industry since 2017, based on several relevant parameters, such as year of partnership, type of partnership (acquisitions, asset acquisitions, commercialization agreements, commercialization and distribution agreements, distribution agreements, product development agreements storage and distribution agreements and others), most active players (in terms of number of deals inked) and regional distribution of partnership activity.

Chapter 10 features an in-depth analysis various recent developments / trends related to global cell cytometry domain, offering insights on the funding activity in this domain, based on several relevant parameters, such as year of funding, type of funding, amount invested (USD Million), most active players (in terms of number of instances and amount raised), most active investors (in terms of number of instances), and geographical regions. In addition, it provides information on the analysis of the global events attended by the participants, based on several relevant parameters, such as year of event, event platform, type of event, most active organizers (in terms of number of events) geographical regions and most active organizations (in terms of number of participants).

Chapter 11 provides an insightful analysis of the patents that have been filed / granted for cell cytometry, since 2020, taking into consideration various relevant parameters, such as type of patent, publication year, geographical location, CPC symbols, emerging focus areas, type of organization, leading players (in terms of number of patents granted / filed) and patent characteristics. In addition, the chapter includes a detailed patent benchmarking and an insightful valuation analysis.

Chapter 12 provides an insightful market forecast analysis, highlighting the likely growth of the cell cytometry market, till the year 2035. In addition, we estimated the likely distribution of the current and forecasted opportunity across the type of cytometer (high throughput flow cytometers and image cytometers), company size (very small, small, mid-sized, large, and very large) and key geographical regions (North America, Europe, Asia-Pacific, and Rest of the World).

Chapter 13 is a summary of the overall report, presenting insights on the contemporary market trends and the likely evolution of the cell cytometry market.

Chapter 14 is a collection of interview transcripts of the discussions that were held key stakeholders in the industry.

Chapter 15 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 16 is an appendix, which contains a list of companies and organizations mentioned in this report.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Key Questions Answered
  • 1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Cell Cytometry
    • 3.2.1. Flow Cytometry
      • 3.2.1.1. High Throughput Flow Cytometry
    • 3.2.2 Image Cytometry
  • 3.3. Advantages and Limitations of Cell Cytometry
  • 3.4. Prevalent Trends Related to Cell Cytometry
    • 3.4.1. Key Historical Trends
    • 3.4.2. Emerging Focus Area
    • 3.4.3. Geographical Activity

4. HIGH THROUGHPUT FLOW CYTOMETERS: MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. High Throughput Flow Cytometers: Overall Market Landscape
    • 4.2.1. Analysis by Type of High Throughput Flow Cytometer
    • 4.2.2. Analysis by Throughput Rate
    • 4.2.3. Analysis by Detection Rate
    • 4.2.4. Analysis by Type of Plate Format
    • 4.2.5. Analysis by Number of Color Channels
    • 4.2.6. Analysis by Number of Detection Channels
    • 4.2.7. Analysis by Number of Laser Channels
    • 4.2.8. Analysis by Product Dimensions
    • 4.2.9. Analysis by Sample Volume
    • 4.2.10. Analysis by Type of Detection Mechanism
    • 4.2.11 Analysis by Application(s)
  • 4.3. High Throughput Flow Cytometers: Developer Landscape
    • 4.3.1 Analysis by Year of Establishment
    • 4.3.2 Analysis by Company Size
    • 4.3.3 Analysis by Location of Headquarters
    • 4.3.4 Most Active Players: Analysis by Number of Products Offered

5. PRODUCT COMPETITIVENESS ANALYSIS: HIGH THROUGHPUT FLOW CYTOMETERS

  • 5.1. Chapter Overview
  • 5.2. Assumptions / Key Parameters
  • 5.3. Methodology
  • 5.4. Product Competitiveness Analysis
    • 5.4.1. Product Competitiveness Analysis: High Throughput Flow Cytometers offered

by Developers based in North America

    • 5.4.2. Product Competitiveness Analysis: High Throughput Flow Cytometers offered

by Developers based in Europe and Asia

6. IMAGE CYTOMETERS: MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Image Cytometers: Overall Market Landscape
    • 6.2.1. Analysis by Type of Image Cytometer
    • 6.2.2. Analysis by Processing Time
    • 6.2.3. Analysis by Type of Plate Format
    • 6.2.4. Analysis by Output Format
    • 6.2.5. Analysis by Sample Volume
    • 6.2.6. Analysis by Product Dimensions
    • 6.2.7. Analysis by Application(s)
  • 6.3. Image Cytometers: Developer Landscape
    • 6.3.1. Analysis by Year of Establishment
    • 6.3.2. Analysis by Company Size
    • 6.3.3. Analysis by Location of Headquarters
    • 6.3.4. Most Active Players: Analysis by Number of Products Offered

7. PRODUCT COMPETITIVENESS ANALYSIS: IMAGE CYTOMETERS

  • 7.1. Chapter Overview
  • 7.2. Assumptions / Key Parameters
  • 7.3. Methodology
  • 7.4. Product Competitiveness Analysis
    • 7.4.1. Product Competitiveness Analysis: Image Cytometers offered by Developers based in North America
    • 7.4.2. Product Competitiveness Analysis: Image Cytometers offered by Developers based in Europe and Asia

8. GLOBAL CELL CYTOMETRY: COMPANY PROFILES

  • 8.1. Chapter Overview
  • 8.2. Agilent
    • 8.2.1. Company Overview
    • 8.2.2. Recent Developments and Future Outlook
  • 8.3. Beckman Coulter Life Sciences
    • 8.3.1. Company Overview
    • 8.3.2. Recent Developments and Future Outlook
  • 8.4. Becton Dickinson
    • 8.4.1. Company Overview
    • 8.4.2. Recent Developments and Future Outlook
  • 8.5. Bio-Rad
    • 8.5.1. Company Overview
    • 8.5.2. Recent Developments and Future Outlook
  • 8.6. Chemometec
    • 8.6.1. Company Overview
    • 8.6.2. Recent Developments and Future Outlook
  • 8.7. Milkotronic
    • 8.7.1. Company Overview
    • 8.7.2. Recent Developments and Future Outlook
  • 8.8. Nexcelom Bioscience
    • 8.8.1. Company Overview
    • 8.8.2. Recent Developments and Future Outlook
  • 8.9. Sartorius
    • 8.9.1. Company Overview
    • 8.9.2. Recent Developments and Future Outlook
  • 8.10. Sony Biotechnology
    • 8.10.1. Company Overview
    • 8.10.2. Recent Developments and Future Outlook
  • 8.11. ThermoFisher Scientific
    • 8.11.1. Company Overview
    • 8.11.2. Recent Developments and Future Outlook
  • 8.12. Union Biometrica
    • 8.12.1. Company Overview
    • 8.12.2. Recent Developments and Future Outlook

9. GLOBAL CELL CYTOMETYRY: PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. List of Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Most Active Players: Analysis by Number of Partnerships
    • 9.3.4. Regional Analysis
    • 9.3.5. Intercontinental and Intracontinental Agreements

10. RECENT DEVELOPMENTS

  • 10.1. Chapter Overview
  • 10.2. Global Cell Cytometry: Funding and Investment Analysis
    • 10.2.1. Types of Funding
    • 10.2.2. List of Funding and Investments
    • 10.2.3. Analysis by Year of Investment
    • 10.2.4. Analysis by Type of Funding
    • 10.2.5. Analysis by Amount Invested
    • 10.2.6. Most Active Players: Analysis by Number of Funding Instances
    • 10.2.7. Most Active Players: Analysis by Amount Raised
    • 10.2.8. Most Active Investors: Analysis by Number of Funding Instances
  • 10.3. Global Cell Cytometry: Global Event Analysis
    • 10.3.1. List of Global Events
      • 10.3.1.1. Analysis by Year of Event
      • 10.3.1.2. Analysis by Event Platform
      • 10.3.1.3. Analysis by Type of Events
      • 10.3.1.4. Analysis by Geography
      • 10.3.1.5. Most Active Event Organizers: Analysis by Number of Events
      • 10.3.1.6. Most Active Organizations: Analysis by Number of Participants
  • 10.4. Concluding Remarks

11. PATENT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
    • 11.2.1. Analysis by Type of Patent
    • 11.2.2. Analysis by Patent Publication Year
    • 11.2.3. Analysis by Annual Number of Granted Patents and Patent Applications
    • 11.2.4. Analysis by Geographical Location
    • 11.2.5. Analysis by CPC Symbols
    • 11.2.6. Word Cloud: Emerging Focus Areas
    • 11.2.7. Analysis by Type of Organization
    • 11.2.8. Leading Industry Players: Analysis by Number of Patents
    • 11.2.9. Leading Non-Industry Players: Analysis by Number of Patents
  • 11.3. Cell Cytometry: Patent Benchmarking Analysis
    • 11.3.1. Analysis by Patent Characteristics
  • 11.4. Cell Cytometry: Patent Valuation Analysis
  • 11.5. Leading Patents by Number of Citations

12. MARKET FORECAST

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Methodology
  • 12.3. Global Cell Cytometry Market, 2022-2035
    • 12.3.1 Global Cell Cytometry Market: Distribution by Type of Cell Cytometer, 2022 and 2035
      • 12.3.1.1. Cell Cytometry Market for High Throughput Flow Cytometers, 2022-2035
      • 12.3.1.2. Cell Cytometry Market for Image Cytometers, 2022-2035
    • 12.3.2. Global Cell Cytometry Market: Distribution by Company Size, 2022 and 2035
      • 12.3.2.1. Cell Cytometry Market for Very Small Companies, 2022-2035
      • 12.3.2.2. Cell Cytometry Market for Small Companies, 2022-2035
      • 12.3.2.3. Cell Cytometry Market for Mid-sized Companies, 2022-2035
      • 12.3.2.4. Cell Cytometry Market for Large Companies, 2022-2035
      • 12.3.2.5. Cell Cytometry Market for Very Large Companies, 2022-2035
    • 12.3.3. Global Cell Cytometry Market: Distribution by Key Geographical Regions, 2022 and 2035
      • 12.3.3.1. Cell Cytometry Market in North America, 2022-2035
      • 12.3.3.2. Cell Cytometry Market in Europe, 2022-2035
      • 12.3.3.3. Cell Cytometry Market in Asia, 2022-2035
      • 12.3.3.4. Cell Cytometry Market in Rest of the World, 2022-2035

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

LIST OF TABLES

  • Table 4.1 High Throughput Flow Cytometers: Information on Type of High Throughput Flow Cytometer and Throughput Rate
  • Table 4.2 High Throughput Flow Cytometers: Information on Detection Rate
  • Table 4.3 High Throughput Flow Cytometers: Information on Type of Plate Format
  • Table 4.4 High Throughput Flow Cytometers: Information on Type of Color Channel
  • Table 4.5 High Throughput Flow Cytometers: Information on Type of Detection Channel
  • Table 4.6 High Throughput Flow Cytometers: Information on Type of Laser Channel, Product Dimensions and Patented Technology
  • Table 4.7 High Throughput Flow Cytometers: Information on Automation Availability, Availability of Automatic Sampling and Sample Volume
  • Table 4.8 High Throughput Flow Cytometers: Information on Type of Detection Mechanism
  • Table 4.9 High Throughput Flow Cytometers: Information on Application(s)
  • Table 4.10 High Throughput Flow Cytometer Developers: Information on Year of Establishment, Company Size and Location of Headquarters
  • Table 6.1 Image Cytometer: Information on Type of Image Cytometer
  • Table 6.2 Image Cytometers: Information on Processing Time
  • Table 6.3 Image Cytometer: Information on Type of Plate Format and Magnification
  • Table 6.4 Image Cytometer: Information on Output Format
  • Table 6.5 Image Cytometer: Information on Sample Volume and Product Dimensions
  • Table 6.6 Image Cytometers: Information on Application(s)
  • Table 6.7 Image Cytometer Developers: Information on Year of Establishment, Company Size and Location of Headquarters
  • Table 8.1 List of Companies Profiled
  • Table 8.2 Agilent: Company Overview
  • Table 8.3 Agilent: Recent Developments and Future Outlook
  • Table 8.4 Beckman Coulter Life Sciences: Company Overview
  • Table 8.5 Beckman Coulter Life Sciences: Recent Developments and Future Outlook
  • Table 8.6 Becton Dickinson: Company Overview
  • Table 8.7 Becton Dickinson: Recent Developments and Future Outlook
  • Table 8.8 Bio-Rad: Company Overview
  • Table 8.9 Bio-Rad: Recent Developments and Future Outlook
  • Table 8.10 Chemometec: Company Overview
  • Table 8.11 Chemotec: Recent Developments and Future Outlook
  • Table 8.12 Easycounter: Company Overview
  • Table 8.13 Nexcelom Bioscinces: Company Overview
  • Table 8.14 Sartorius: Company Overview
  • Table 8.15 Sartorius: Recent Developments and Future Outlook
  • Table 8.16 Sony Biotechnology: Company Overview
  • Table 8.17 Thermo Fischer Scientific: Company Overview
  • Table 8.18 Thermo Fischer Scientific: Recent Developments and Future Outlook
  • Table 8.19 Union Biometrica: Company Overview
  • Table 8.20 Union Biometrica: Recent Developments and Future Outlook
  • Table 9.1 Global Cell Cytometry: List of Partnerships and Collaborations, 2017- 2022
  • Table 10.1 Global Cell Cytometry: List of Funding and Investments, 2017-2022
  • Table 10.2 Global Cell Cytometry: List of Global Events, 2018- 2022
  • Table 11.1 Patent Analysis: Prominent CPC Symbols
  • Table 11.2 Patent Analysis: List of Top CPC Symbols
  • Table 11.3 Patent Analysis: Most Popular CPC Symbols
  • Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
  • Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
  • Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
  • Table 11.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
  • Table 15.1 High Throughput Flow Cytometers: Distribution by Type of High Throughput Flow Cytometer
  • Table 15.2 High Throughput Flow Cytometers: Distribution by Throughput Rate
  • Table 15.3 High Throughput Flow Cytometers: Distribution by Detection Rate
  • Table 15.4 High Throughput Flow Cytometers: Distribution by Type of Plate Format
  • Table 15.5 High Throughput Flow Cytometers: Distribution by Type of Color Channel
  • Table 15.6 High Throughput Flow Cytometers: Distribution by Type of Detection Channel
  • Table 15.7 High Throughput Flow Cytometers: Distribution by Type of Laser Channel
  • Table 15.8 High Throughput Flow Cytometers: Distribution by Product Dimensions
  • Table 15.9 High Throughput Flow Cytometers: Distribution by Sample Volume (in μl)
  • Table 15.10 High Throughput Flow Cytometers: Distribution by Type of Detection Mechanism
  • Table 15.11 High Throughput Flow Cytometers: Distribution by Application(s)
  • Table 15.12 High Throughput Flow Cytometer Developers: Distribution by Year of Establishment
  • Table 15.13 High Throughput Flow Cytometer Developers: Distribution by Company Size
  • Table 15.14 High Throughput Flow Cytometer Developers: Distribution by Location of Headquarters
  • Table 15.15 Leading High Throughput Flow Cytometer Developers: Distribution by Number of Products Offered
  • Table 15.16 Image Cytometers: Distribution by Type of Image Cytometer
  • Table 15.17 Image Cytometers: Distribution by Processing Time
  • Table 15.18 Image Cytometers: Distribution by Type of Plate Format
  • Table 15.19 Image Cytometers: Distribution by Output Format
  • Table 15.20 Image Cytometers: Distribution by Sample Volume
  • Table 15.21 Image Cytometers: Distribution by Product Dimensions
  • Table 15.22 Image Cytometers: Distribution by Application(s)
  • Table 15.23 Image Cytometer Developers: Distribution by Year of Establishment
  • Table 15.24 Image Cytometer Developers: Distribution by Company Size
  • Table 15.25 Image Cytometer Developers: Distribution by Location of Headquarters
  • Table 15.26 Leading Image Cytometer Developers: Distribution by Number of Products Offered
  • Table 15.27 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022
  • Table 15.28 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 15.29 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
  • Table 15.30 Most Active Players: Distribution by Number of Partnerships
  • Table 15.31 Partnerships and Collaborations: Regional Analysis
  • Table 15.32 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Table 15.33 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2017-2022
  • Table 15.34 Funding and Investment Analysis: Distribution by Type of Funding
  • Table 15.35 Funding and Investment Analysis: Cumulative Year-wise Distribution by Amount Invested, 2017-2022 (USD Million)
  • Table 15.36 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Table 15.37 Funding and Investment Analysis: Year-Wise Distribution of Instances by Type of Funding and Total Amount Invested, 2017-2022 (USD Million)
  • Table 15.38 Most Active Players: Distribution by Number of Funding Instances
  • Table 15.39 Most Active Players: Distribution by Amount Raised (USD Million)
  • Table 15.40 Most Active Investors: Distribution by Number of Funding Instances
  • Table 15.41 Global Events: Cumulative Half yearly Trend, 2018 - H2 2022
  • Table 15.42 Global Events: Distribution by Event Platform
  • Table 15.43 Global Events: Distribution by Type of Event
  • Table 15.44 Global Events: Regional Distribution of Event
  • Table 15.45 Most Active Event Organizers: Distribution by Number of Events
  • Table 15.46 Most Active Organizations: Distribution by Number of Participants
  • Table 15.47 Patent Analysis: Distribution by Type of Patent
  • Table 15.48 Patent Analysis: Cumulative Distribution by Publication Year, 2020-2022
  • Table 15.49 Patent Analysis: Cumulative Distribution by Annual Number of Granted Patents and Patent Applications, 2020-2022
  • Table 15.50 Patent Analysis: Distribution by Geographical Location
  • Table 15.51 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2020-2022
  • Table 15.52 Leading Industry Players: Distribution by Number of Patents
  • Table 15.53 Leading Non-Industry Players: Distribution by Number of Patents
  • Table 15.54 Leading Individual Assignees: Distribution by Number of Patents
  • Table 15.55 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
  • Table 15.56 Patent Analysis: Year-wise Distribution of Patents by Age
  • Table 15.57 Cell Cytometry: Patent Valuation Analysis
  • Table 15.58 Global Cell Cytometry Market, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.59 Global Cell Cytometry Market: Distribution by Type of Cytometer, 2022 and 2035
  • Table 15.60 Cell Cytometry Market for High Throughput Flow Cytometers, 2022- 2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.61 Cell Cytometry Market for Image Cytometers, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.62 Global Cell Cytometry Market: Distribution by Company Size, 2022 and 2035
  • Table 15.63 Cell Cytometry Market for Very Small Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.64 Cell Cytometry Market for Small Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.65 Cell Cytometry Market for Mid-Sized Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.66 Cell Cytometry Market for Large Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.67 Cell Cytometry Market for Very Large Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.68 Global Cell Cytometry Market: Distribution by Key Geographical Regions, 2022 and 2035
  • Table 15.69 Cell Cytometry Market in North America, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.70 Cell Cytometry Market in Europe, 2022-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.71 Cell Cytometry Market in Asia-Pacific, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 15.72 Cell Cytometry Market in Rest of the World, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)

LIST OF FIGURES

  • Figure 2.1 Executive Summary: High Throughput Flow Cytometers Market Landscape
  • Figure 2.2 Executive Summary: Image Cytometers Market Landscape
  • Figure 2.3 Executive Summary: Partnerships and Collaborations
  • Figure 2.4 Executive Summary: Funding and Investment Analysis
  • Figure 2.5 Executive Summary: Global Events
  • Figure 2.6 Executive Summary: Patent Analysis
  • Figure 2.7 Executive Summary: Market Forecast
  • Figure 3.1 Types of Cytometers
  • Figure 3.2 Advantages of Different Types of Cytometry
  • Figure 3.3 Limitations of Different Types of Cytometry
  • Figure 4.1 High Throughput Flow Cytometers: Distribution by Type of High Throughput Flow Cytometer
  • Figure 4.2 High Throughput Flow Cytometers: Distribution by Throughput Rate
  • Figure 4.3 High Throughput Flow Cytometers: Distribution by Detection Rate
  • Figure 4.4 High Throughput Flow Cytometers: Distribution by Type of Plate Format
  • Figure 4.5 High Throughput Flow Cytometers: Distribution by Number of Color Channels
  • Figure 4.6 High Throughput Flow Cytometers: Distribution by Number of Detection Channels
  • Figure 4.7 High Throughput Flow Cytometers: Distribution by Number of Laser Channels
  • Figure 4.8 High Throughput Flow Cytometers: Distribution by Product Dimensions
  • Figure 4.9 High Throughput Flow Cytometers: Distribution by Sample Volume (in μl)
  • Figure 4.10 High Throughput Flow Cytometers: Distribution by Type of Detection Mechanism
  • Figure 4.11 High Throughput Flow Cytometers: Distribution by Application(s)
  • Figure 4.12 High Throughput Flow Cytometer Developers: Distribution by Year of Establishment
  • Figure 4.13 High Throughput Flow Cytometer Developers: Distribution by Company Size
  • Figure 4.14 High Throughput Flow Cytometer Developers: Distribution by Location of Headquarters
  • Figure 4.15 Leading High Throughput Flow Cytometer Developers: Distribution by Number of Products Offered
  • Figure 5.1 Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Players based in North America
  • Figure 5.2 Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Players based in Europe and Asia-Pacific
  • Figure 6.1 Image Cytometer: Distribution by Type of Image Cytometer
  • Figure 6.2 Image Cytometer: Distribution by Processing Time
  • Figure 6.3 Image Cytometer: Distribution by Type of Plate Format
  • Figure 6.4 Image Cytometers: Distribution by Output Format
  • Figure 6.5 Image Cytometers: Distribution by Sample Volume
  • Figure 6.6 Image Cytometer: Distribution by Product Dimensions
  • Figure 6.7 Image Cytometer: Distribution by Application(s)
  • Figure 6.8 Image Cytometer Developers: Distribution by Year of Establishment
  • Figure 6.9 Image Cytometer Developers: Distribution by Company Size
  • Figure 6.10 Image Cytometer Developers: Distribution by Location of Headquarters
  • Figure 6.11 Leading Image Cytometer Developers: Distribution by Number of Products Offered
  • Figure 7.1 Product Competitiveness Analysis: Image Cytometers offered by Players based in North America
  • Figure 7.2 Product Competitiveness Analysis: Image Cytometers offered by Players based in Europe and Asia-Pacific
  • Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022
  • Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
  • Figure 9.4 Most Active Players: Distribution by Number of Partnerships
  • Figure 9.5 Partnerships and Collaborations: Regional Analysis
  • Figure 9.6 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Figure 10.1 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2017-2022
  • Figure 10.2 Funding and Investment Analysis: Distribution by Type of Funding
  • Figure 10.3 Funding and Investment Analysis: Cumulative Year-wise Distribution by Amount Invested, 2017-2022 (USD Million)
  • Figure 10.4 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Figure 10.5 Funding and Investment Analysis: Year-Wise Distribution of Instances by Type of Funding and Total Amount Invested, 2017-2022 (USD Million)
  • Figure 10.6 Most Active Players: Distribution by Number of Funding Instances
  • Figure 10.7 Most Active Players: Distribution by Amount Raised (USD Million)
  • Figure 10.8 Most Active Investors: Distribution by Number of Funding Instances
  • Figure 10.9 Global Events: Cumulative Half yearly Trend, 2018 - H2 2022
  • Figure 10.10 Global Events: Distribution by Event Platform
  • Figure 10.11 Global Events: Distribution by Type of Event
  • Figure 10.12 Global Events: Regional Distribution of Events
  • Figure 10.13 Most Active Event Organizers: Distribution by Number of Events
  • Figure 10.14 Most Active Organizations: Distribution by Number of Participants
  • Figure 11.1 Patent Analysis: Distribution by Type of Patent
  • Figure 11.2 Patent Analysis: Cumulative Distribution by Publication Year, 2020-2022 Figure 11.3 Patent Analysis: Cumulative Distribution by Annual Number of Granted Patents and Patent Applications, 2020-2022
  • Figure 11.4 Patent Analysis: Distribution by Geographical Location
  • Figure 11.5 Patent Analysis: Distribution by CPC Symbols
  • Figure 11.6 Word Cloud: Emerging Focus Areas
  • Figure 11.7 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2020-2022
  • Figure 11.8 Leading Industry Players: Distribution by Number of Patents
  • Figure 11.9 Leading Non-Industry Players: Distribution by Number of Patents
  • Figure 11.10 Leading Individual Assignees: Distribution by Number of Patents
  • Figure 11.11 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
  • Figure 11.12 Patent Analysis: Year-wise Distribution of Patents by Age
  • Figure 11.13 Cell Cytometry: Patent Valuation Analysis
  • Figure 12.1 Global Cell Cytometry Market, 2022-2035 (USD Million)
  • Figure 12.2 Global Cell Cytometry Market: Distribution by Type of Cell Cytometer, 2022 and 2035
  • Figure 12.3 Cell Cytometry Market for High Throughput Flow Cytometers, 2022- 2035 (USD Million)
  • Figure 12.4 Cell Cytometry Market for Image Cytometers, 2022-2035 (USD Million)
  • Figure 12.5 Global Cell Cytometry Market: Distribution by Company Size, 2022 and 2035
  • Figure 12.6 Cell Cytometry Market for Very Small Companies, 2022-2035 (USD Million)
  • Figure 12.7 Cell Cytometry Market for Small Companies, 2022-2035 (USD Million)
  • Figure 12.8 Cell Cytometry Market for Mid-sized Companies, 2022-2035 (USD Million)
  • Figure 12.9 Cell Cytometry Market for Large Companies, 2022-2035 (USD Million)
  • Figure 12.10 Cell Cytometry Market for Very Large Companies, 2022-2035 (USD Million)
  • Figure 12.11 Global Cell Cytometry Market: Distribution by Key Geographical Regions, 2022 and 2035
  • Figure 12.12 Cell Cytometry Market in North America, 2022-2035 (USD Million)
  • Figure 12.13 Cell Cytometry Market in Europe, 2022-2035 (USD Million)
  • Figure 12.14 Cell Cytometry Market in Asia, 2022-2035 (USD Million)
  • Figure 12.15 Cell Cytometry Market in Rest of the World, 2022-2035 (USD Million)
  • Figure 13.1 Concluding Remarks: High Throughput Flow Cytometers Market Landscape
  • Figure 13.2 Concluding Remarks: Image Cytometers Market Landscape
  • Figure 13.3 Concluding Remarks: Partnerships and Collaborations
  • Figure 13.4 Concluding Remarks: Funding and Investment Analysis
  • Figure 13.5 Concluding Remarks: Global Events
  • Figure 13.6 Concluding Remarks: Patent Analysis
  • Figure 13.7 Concluding Remarks: Market Forecast